Medicaid Spending on Opioid Addiction Treatment Has Risen Dramatically: Report

white pills and bottle spilled over money

A new report finds spending on Medicaid-covered prescriptions for the treatment of opioid use disorder and opioid overdose increased dramatically between 2011 and 2016, according to NPR. The largest increase occurred after 2014.

The report by the Urban Institute found between 2011 and 2016, Medicaid spending on opioid use disorder treatment prescriptions for buprenorphine, naltrexone, and naloxone increased 136 percent, from $394.2 million to $929.9 million. Most of the money went to buprenorphine (sold as Suboxone), for which spending increased 98 percent between 2011 and 2016, from $380.9 million to $753.9 million.

Medicaid spending on naltrexone (sold as Revia and Vivitrol) rose from $13.3 million in 2011 to 156.3 million in 2016, while spending on naloxone (sold as Narcan and Evzio) increased from $0.02 million in 2011 to $19.7 million in 2016.

Medicaid is Essential to Addiction Treatment - Call Your Senators: Vote NO to the American Health Care Act

Tell your Senator to protect the Medicaid expansion and Essential Health Benefits so that people with substance use disorder can receive the treatment they need. If Medicaid Expansion is repealed, states hardest hit by the opioid epidemic would be at greatest risk for reductions in coverage.

Leave a Comment

Please leave a comment below to contribute to the discussion. If you have a specific question, please contact a Parent Specialist, who will provide you with one-on-one help.

Your email address will not be published. Required fields are marked *